AMAG Pharmaceuticals, Inc. v. Silverstrand Instruments
Certiorari Denied
Petition for certiorari denied on October 7, 2013.
Issue
Whether, in order to survive a motion to dismiss, a plaintiff asserting a claim under Section 11 of the Securities Act of 1933 premised on an alleged violation of SEC regulations must plead facts establishing that the allegedly omitted information is material under Basic Inc. v. Levinson and Matrixx Inc. v. Siracusano.
Jun 13, 2013Petition for a writ of certiorari filed. (Response due July 17, 2013)
Jun 21, 2013Order extending time to file response to petition to and including August 16, 2013.
Aug 16, 2013Brief of respondents Silverstrand Investments, et al. in opposition filed.
Aug 29, 2013Reply of petitioners AMAG Pharmaceuticals, Inc., et al. filed.
Sep 4, 2013DISTRIBUTED for Conference of September 30, 2013.
Oct 7, 2013Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.
Recommended Citation: AMAG Pharmaceuticals, Inc. v. Silverstrand Instruments, SCOTUSblog, https://www.scotusblog.com/cases/amag-pharmaceuticals-inc-v-silverstrand-instruments/